Gen store Transfluor® assay by iCyte™ imaging cytometer - An advanced cell based screening technology applicable to GPCRs - Kazuo Ozawa Etsuo Shinohara Sachiko Karaki Olympus Co. Genome Medical Business Division January 30, 2004 Norak Biosciences A biotechnology company based in Research Triangle Park, NC, utilizing its Transfluor® technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors (GPCRs). Transfluor® technology A patented, universal GPCR drug discovery technology based on the translocation of arrestin protein from cytosol to GPCR on the membrane. Olympus Confocal universal GPCR drug discovery technology based on the translocation of arrestin protein from cytosol to GPCR on the membrane.... Jan 28, 2024
Gen store Cellomics Cellprofiler Atto Transfluor Ranking of β2 Adrenergic Receptor Agonists and Antagonists Using a Cell-Based GPCR Signaling Application Chandrasekaran Vasudevan and Jeffrey R. Haskins Abstract G-protein coupled receptor (GPCR) sign... Jan 28, 2024
